ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

NCT03587740 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: T-DM1

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]